Document:

exv10w1

 

Exhibit 10.1

December 14, 2007

PERSONAL AND CONFIDENTIAL

Ms. Mariam Morris, Chief Accounting Officer

4520 East West Highway, 3rd Floor

Bethesda, Maryland 20814

     Re:     Amendment to Employment Agreement

Dear Mariam:

     This letter will reflect the agreement between you and Sucampo Pharmaceuticals, Inc. (the
“Company”) upon certain amendments to the terms of the Amended Employment Agreement between you and
the Company dated May 12, 2007.

     Effective as of January 1, 2008, your Base Salary will be increased to the annual rate of
$220,000. In addition, effective as of January 1, 2008, you ceased to serve as the Company’s Chief
Accounting Officer and assumed the position of Chief Financial Officer.

     Consistent with the requirements for modification set forth in Section 6.3 of the Amended
Employment Agreement, this letter will document the mutual agreement between you and the Company to
amend Section 3.1(a) of your Amended Employment Agreement to reflect the foregoing increase in Base
Salary. This letter further documents the mutual agreement between you and the Company to modify
your Amended Employment Agreement to reflect the foregoing change in your title and related
responsibilities as follows: (1) “Chief Accounting Officer” is changed to “Chief Financial Officer”
in Paragraph 5 of the prologue to your Amended Employment Agreement, (2) “Chief Accounting Officer”
is changed to “Chief Financial Officer” in Section 1.1 of your Amended Employment Agreement, (3)
“Chief Financial Officer” is removed from the list set forth in Section 1.1 of your Amended
Employment Agreement naming those individuals or entities who may assign you duties, and (4) “Chief
Financial Officer” is removed from the list set forth in Section 4.1(b)(vi) of your Amended
Employment Agreement naming those individuals or entities whose directives you are obliged to carry
out.

     The foregoing are the only changes to the terms of the Amended Employment Agreement to be made
at this time. Please indicate your agreement to these modifications of the Employment Agreement by
countersigning the enclosed copy of this letter in the space provided below and returning the same
to me for the Company’s files.

     Thank you for your cooperation.

	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/  RYUJI UENO
 	 
	 	Ryuji Ueno, M.D., Ph.D 	 
	 	President 	 
	 

Acknowledged and accepted this 14th day of December, 2007.

	 	 	 	 	 
	 	 	 
	/s/  MARIAM MORRIS
 	 	 
	Mariam Morrisexv10w2

 

Exhibit 10.2

November 28, 2007

PERSONAL AND CONFIDENTIAL

Ms. Mariam Morris, Chief Accounting Officer

4520 East West Highway, 3rd Floor

Bethesda, Maryland 20814

     Re:     Amendment to Employment Agreement

Dear Mariam:

     This letter will reflect the agreement between you and Sucampo Pharmaceuticals, Inc. (the
“Company”) upon certain amendments to the terms of the Employment Agreement between you and the
Company dated May 12, 2007.

     Effective as of the first payroll period in June 2007, your Base Salary has been increased to
the annual rate of $168,000. In addition, effective immediately, your Compensation Upon Severance
in the event the Company terminates (or elects not to renew) your Employment Agreement “without
cause,” or upon disability pursuant to Section 4.2 of the Agreement, or in the event you terminate
the Agreement for “good reason” has been altered to increase your lump-sum severance to a payment
equal to six (6) months of your then-current base salary. Your Compensation upon Severance has
also been altered to extend the period for which you are entitled to receive reimbursement for the
cost of continued health insurance coverage to a maximum of six (6) months after termination.

     Consistent with the requirements for modification set forth in Section 6.3 of the Employment
Agreement, this letter will document the mutual agreement between you and the Company to amend (1)
Section 3.1(a) of your Employment Agreement to reflect the foregoing increase in Base Salary, (2)
Section 4.4(a)(iii) of that agreement to reflect the foregoing increase in your Compensation Upon
Severance, and (3) Section 4.1(a),(i) of that agreement to alter the definition of “Benefit Period”
to mean “six (6) month period” rather than “two (2) month period.”

     The foregoing are the only changes to the terms of the Employment Agreement to be made at this
time. Please indicate your agreement to these modifications of the Employment Agreement by
countersigning the enclosed copy of this letter in the space provided below and returning the same
to me for the Company’s files.

     Thank you for your cooperation.

	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/  RYUJI UENO
 	 
	 	Ryuji Ueno, M.D., Ph.D 	 
	 	President 	 
	 

Acknowledged and accepted this 10th day of December, 2007.

	 	 	 	 	 
	 	 	 
	/s/  MARIAM MORRIS 	 	 
	Mariam Morrisexv10w3

 

Exhibit 10.3

November 15, 2007

PERSONAL AND CONFIDENTIAL

Mr. Brad Fackler, Executive VP, Commercial Operations

4520 East West Highway, 3rd Floor

Bethesda, Maryland 20814

     Re:     Amendment to Employment Agreement

Dear Mr. Fackler:

     This letter will reflect the agreement between you and Sucampo Pharmaceuticals, Inc. (the
“Company”) upon certain amendments to the terms of the Employment Agreement between you and the
Company dated June 16, 2006.

     Effective as of the first payroll period in June 2007, your Base Salary has been increased to
the annual rate of $231,000. In addition, effective immediately, your Compensation Upon Severance
in the event the Company terminates (or elects not to renew) your Employment Agreement “without
cause,” or upon disability pursuant to Section 4.2 of the Agreement, or in the event you terminate
the Agreement for “good reason” has been altered to increase your lump-sum severance to a payment
equal to six (6) months of your then-current base salary. Your Compensation Upon Severance has
also been altered to extend the period for which you are entitled to receive reimbursement for the
cost of continued health insurance coverage to a maximum of six (6) months after termination.

     Consistent with the requirements for modification set forth in Section 6.3 of the Employment
Agreement, this letter will document the mutual agreement between you and the Company to amend (1)
Section 3.1(a) of your Employment Agreement to reflect the foregoing increase in Base Salary, (2)
Section 4.4(a)(iii) of that agreement to reflect the foregoing increase in your Compensation Upon
Severance, and (3) Section 4.1(a) of that agreement to alter the definition of “Benefit Period” to
mean “six (6) month period” rather than “two (2) month period.”

     The foregoing are the only changes to the terms of the Employment Agreement to be made at this
time. Please indicate your agreement to these modifications of the Employment Agreement by
countersigning the enclosed copy of this letter in the space provided below and returning the same
to me for the Company’s files.

     Thank you for your cooperation.

	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/  RYUJI UENO
 	 
	 	Ryuji Ueno, M.D., Ph.D 	 
	 	President 	 
	 

Acknowledged and accepted this 7th day of December, 2007.

	 	 	 	 	 
	 	 	 
	/s/  BRAD FACKLER 	 	 
	Brad Facklerexv10w4

 

Exhibit 10.4

November 16, 2007

PERSONAL AND CONFIDENTIAL

Dr. Gayle R. Dolecek, Ph.D., Sr. VP, R&D

4520 East West Highway, 3rd Floor

Bethesda, Maryland 20814

     Re:     Amendment to Employment Agreement

Dear Dr. Dolecek:

     This letter will reflect the agreement between you and Sucampo Pharmaceuticals, Inc. (the
“Company”) upon certain amendments to the terms of the Employment Agreement between you and the
Company dated June 16, 2006.

     Effective as of the first payroll period in June 2007, your Base Salary has been increased to
the annual rate of $170,500. In addition, effective immediately, your Compensation Upon Severance
in the event the Company terminates (or elects not to renew) your Employment Agreement “without
cause,” or upon disability pursuant to Section 4.2 of the Agreement, or in the event you terminate
the Agreement for “good reason” has been altered to increase your lump-sum severance to a payment
equal to six (6) months of your then-current base salary. Your Compensation Upon Severance has also
been altered to extend the period for which you are entitled to receive reimbursement for the cost
of continued health insurance coverage to a maximum of six (6) months after termination.

     Consistent with the requirements for modification set forth in Section 6.3 of the Employment
Agreement, this letter will document the mutual agreement between you and the Company to amend (1)
Section 3.1(a) of your Employment Agreement to reflect the foregoing increase in Base Salary, (2)
Section 4.4(a)(iii) of that agreement to reflect the foregoing increase in your Compensation Upon
Severance, and (3) Section 4.1(a) of that agreement to alter the definition of “Benefit Period” to
mean “six (6) month period” rather than “two (2) month period.”

     The foregoing are the only changes to the terms of the Employment Agreement to be made at this
time. Please indicate your agreement to these modifications of the Employment Agreement by
countersigning the enclosed copy of this letter in the space provided below and returning the same
to me for the Company’s files.

     Thank you for your cooperation.

	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/ RYUJI UENO
 	 
	 	Ryuji Ueno, M.D., Ph.D 	 
	 	President 	 
	 

Acknowledged and accepted this 6th day of December, 2007.

	 	 	 	 	 
	 	 	 
	/s/ GAYLE R. DOLECEK
 	 	 
	Gayle R. Dolecekexv10w5

 

Exhibit 10.5

November 14, 2007

PERSONAL AND CONFIDENTIAL

Ms. Kei Tolliver, VP, Business Development & Company Operation

4520 East West Highway, 3rd Floor

Bethesda, Maryland 20814

     Re:     Amendment to Employment Agreement

Dear Ms. Tolliver:

     This letter will reflect the agreement between you and Sucampo Pharmaceuticals, Inc. (the
“Company”) upon certain amendments to the terms of the Employment Agreement between you and the
Company dated June 16, 2006.

     Effective as of the first payroll period in June 2007, your Base Salary has been increased to
the annual rate of $124,000. In addition, effective immediately, your Compensation Upon Severance
in the event the Company terminates (or elects not to renew) your Employment Agreement “without
cause,” or upon disability pursuant to Section 4.2 of the Agreement, or in the event you terminate
the Agreement for “good reason” has been altered to increase your lump-sum severance to a payment
equal to six (6) months of your then-current base salary. Your Compensation Upon Severance has also
been altered to extend the period for which you are entitled to receive reimbursement for the cost
of continued health insurance coverage to a maximum of six (6) months after termination.

     Consistent with the requirements for modification set forth in Section 6.3 of the Employment
Agreement, this letter will document the mutual agreement between you and the Company to amend (1)
Section 3.1(a) of your Employment Agreement to reflect the foregoing increase in Base Salary, (2)
Section 4.4(a)(iii) of that agreement to reflect the foregoing increase in your Compensation Upon
Severance, and (3) Section 4.1(a) of that agreement to alter the definition of “Benefit Period” to
mean “six (6) month period” rather than “two (2) month period.”

     The foregoing are the only changes to the terms of the Employment Agreement to be made at this
time. Please indicate your agreement to these modifications of the Employment Agreement by
countersigning the enclosed copy of this letter in the space provided below and returning the same
to me for the Company’s files.

     Thank you for your cooperation.

	 	 	 	 	 
	 	Sincerely,

 	 
	 	/s/ RYUJI UENO
 	 
	 	Ryuji Ueno, M.D., Ph.D 	 
	 	President 	 
	 

Acknowledged and accepted this 5th day of December, 2007.

	 	 	 	 	 
	 	 	 
	/s/ KEI TOLLIVER
 	 	 
	Kei Tolliver

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00134-of-00352.parquet"}]]